Viewing Study NCT05803603



Ignite Creation Date: 2024-05-06 @ 6:50 PM
Last Modification Date: 2024-10-26 @ 2:55 PM
Study NCT ID: NCT05803603
Status: COMPLETED
Last Update Posted: 2024-01-25
First Post: 2023-03-23

Brief Title: Social Work Assistance and Stipends for Housing SASH
Sponsor: University of Maryland Baltimore
Organization: University of Maryland Baltimore

Study Overview

Official Title: Social Work Assistance and Stipends for Housing SASH Improving Outcomes for Homeless Patients Receiving Methadone for Opioid Use Disorder
Status: COMPLETED
Status Verified Date: 2024-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SASH
Brief Summary: SASH is a clinical trial feasibility study that will provide an intervention to improve Opioid Use Disorder OUD Quality of Life QOL and housing outcomes for homeless patients receiving Medication for Opiate Use Disorder MOUD The main questions of the study are does a 500 housing stipend for individuals on MOUD increase treatment retention improved quality of life and prevent homelessness
Detailed Description: SASH is a clinical trial feasibility study that will provide an housing stipend for 8 individuals N8 experience homelessness and currently being treated for OUD to improve OUD treatment outcomes QOL and housing outcomes To achieve these goals patients will receive monthly 500 housing stipends that can be used for a broad range of temporary housing included in a list of resources compiled by the study These stipends will be accompanied by Social Work assistance to find permanent housing which will last the full 12 months of the study SASH will recruit OUD patients receiving MOUD who are struggling with homelessness defined as living in an emergency shelter or a place not meant for habitation instead of a fixed regular and adequate nighttime residence This definition is consistent with the one used by the US Department of Housing and Urban Development The patients will be recruited from the University of Maryland Addiction Treatment Program ATP a certified Substance Use Disorder SUD treatment program that provides MOUD and collocates medical care wellness programs and research Patients will be eligible for SASH if they experienced homelessness during at least 15 of the 30 days preceding the dispensing of the first months stipendsSASH will accomplish its goals using the following aims and objectives

AIM 1 Improve OUD outcomes

Hypothesis 1a Patients will miss fewer methadone doses and receive more take-home methadone doses after receiving the stipends and Social Work assistance Endpoint Percentages of missed and take-home methadone doses as recorded by the software tracking methadone-dispensing at the ATP in the 3-month period before the study between Month 3 and 6 of the study and between Month 9 and 12 of the study
Hypothesis 1b Patients will experience an improvement in their OUD after receiving the stipends and Social Work assistance Endpoint OUD Checklist scores completed at Day 0 Month 6 and Month 12 of the study
Hypothesis 1c Patients will use fewer opioids and illicit substances after receiving the stipends and Social Work assistance Endpoint Monthly urine toxicology tests UTT three months before study entry and monthly during the study

AIM 2 Improve QOL

Hypothesis 2a Patients will experience improvement in QOL during the study Endpoint SF-36 scores at Day 0 Month 6 and Month 12 of the study
Hypothesis 2b Patients will report benefit from receiving the stipends and Social Work assistance

AIM 3 Prevent homelessness

Hypothesis 3a The monthly 500 stipends will prevent patients from being homeless Endpoint Percentage of days patients are homeless during the 6-month period stipends are distributed
Hypothesis 3b Patients will be in housing by the end of the study Endpoint Percentage of patients who are homeless or in either permanent or temporary housing by Month 12 of the study

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None